Founded in 2019 by CEO Tim Balz, Kalogon develops smart seating solutions focused on seated health, serving people who sit for extended periods across healthcare, aviation and other settings. Its proprietary technology combines real-time sensors, adaptive surfaces and personalized control to restore circulation, protect skin integrity and reduce fatigue. The company manufactures all products in-house and goes to market via clinical partnerships, major DME distributors and direct sales. Kalogon recently raised $5.75M and plans to use the proceeds to expand operations and advance product development. The article notes returning investors among the new round, but does not disclose revenue or user metrics.

Total raised

$10M

Funding rounds

4

Latest round

Equity

Latest activity

Jun 2026